Skip to main content
. 2019 Sep 20;9:895. doi: 10.3389/fonc.2019.00895

Table 1B.

Association of CIC subtypes with clinicopathological characteristics.

LiT LiM HeCIC
Characteristics N (%) No#n (%) Yes#n (%) χ2 P No#n (%) Yes#n (%) χ2 P No#n (%) Yes#n (%) χ2 P
Total 148 142 (95.9) 6 (4.1) 126 (85.1) 22 (14.9) 38 (25.7) 110 (74.3)
Age (years) 0.466 0.495 1.762 0.184 1.504 0.220
≤ 60 105 (70.9) 100 (95.2) 5 (4.8) 92 (87.6) 13 (12.4) 24 (22.9) 81 (77.1)
>60 43 (29.1) 42 (97.7.4) 1 (2.3) 34 (79.1) 9 (20.9) 14 (32.6) 29 (67.4)
Histological grade 3.949 0.139 0.176 0.916 3.104 0.212
1 16 (10.8) 16 (100.0) 0 (0.0) 14 (87.5) 2 (12.5) 7 (43.8) 9 (56.2)
2 127 (85.8) 122 (96.1) 5 (3.9) 108 (85.0) 19 (15.0) 30 (23.6) 97 (76.4)
3 5 (3.4) 4 (80.0) 1 (20.0) 4 (80) 1 (20) 1 (20.0) 4 (80.0)
TNM stage 1.394 0.498 3.232 0.199 0.499 0.779
I 13 (8.8) 13 (100.0) 0 (0.0) 12 (92.3) 1 (7.7) 3 (23.1) 10 (76.9)
II 91 (61.5) 86 (94.5) 5 (5.5) 80 (87.9) 11 (12.1) 22 (24.2) 69 (75.8)
III 44 (29.7) 43 (97.7) 1 (2.3) 34 (77.3) 10 (22.7) 13 (29.5) 31 (70.5)
Tumor size 0.7825 0.676 2.488 0.288 0.868 0.648
<2 cm 35 (23.6) 34 (97.1) 1 (2.9) 32 (91.4) 3 (8.6) 11 (31.4) 24 (68.6)
2–5 cm 102 (68.9) 97 (95.1) 5 (4.9) 86 (84.3) 16 (15.7) 24 (23.5) 78 (76.5)
> 5 cm 11 (7.4) 11 (100.0) 0 (0.0) 8 (72.7) 3 (27.3) 3 (27.3) 8 (72.7)
Lymph node metastasis 1.609 0.447 2.261 0.323 1.293 0.524
0 62 (41.9) 58 (93.5) 4 (6.5) 53 (85.5) 9 (14.5) 13 (21.0) 49 (79.0)
1–2 36 (24.3) 35 (97.2) 1 (2.8) 33 (91.7) 3 (8.3) 10 (27.8) 26 (72.2)
> 3 50 (33.8) 49 (98.0) 1 (2.0) 40 (80.0) 10 (20.0) 15 (30.0) 35 (70.0)
ER status 0.745 0.391 4.979 0.026 0.214 0.644
Positive 98 (66.2) 95 (96.9) 3 (3.1) 88 (89.8) 10 (10.2) 24 (24.5) 74 (75.5)
Negative 50 (33.8) 47 (94.0) 3 (6.0) 38 (76.0) 12 (24.0) 14 (28.0) 36 (72.0)
PR status 1.672 0.196 3.408 0.065 0.064 0.800
Positive 87 (58.8) 85 (97.7) 2 (2.3) 78 (89.7) 9 (10.3) 23 (26.4) 64 (73.6)
Negative 61 (41.2) 57 (93.4) 4 (6.6) 48 (78.7) 13 (21.3) 15 (24.6) 46 (75.4)
Her2 status 1.865 0.172 0.270 0.603 0.323 0.570
Positive 34 (23.0) 34 (100.0) 0 (0.0) 28 (82.4) 6 (17.6) 10 (29.4) 24 (70.6)
Negative 114 (77.0) 108 (94.7) 6 (5.3) 98 (86.0) 16 (14.0) 28 (24.6) 86 (75.4)
Subtype 8.525 0.074 11.268 0.024 3.442 0.487
Lum A 69 (46.6) 68 (98.6) 1 (146) 65 (94.2) 4 (5.8) 19 (27.5) 50 (72.5)
Lum B (Her2+) 16 (10.8) 14 (87.5) 2 (12.5) 13 (81.3) 3 (18.7) 2 (12.5) 14 (87.5)
Lum B (Her2) 19 (12.8) 19 (100.0) 0 (0.0) 15 (78.9) 4 (21.1) 4 (21.1) 15 (78.9)
Her2+/HR 15 (10.1) 15 (100.0) 0 (0.0) 13 (86.7) 2 (13.3) 6 (40.0) 9 (60.0)
TNBC 29 (19.6) 26 (89.7) 3 (10.3) 20 (69.0) 9 (31.0) 7 (24.1) 22 (75.9)
EGFR status 2.316 0.128 4.215 0.040 0.096 0.757
Positive 108 (73) 102 (94.4) 6 (5.6) 88 (81.5) 20 (18.5) 27 (25.0) 81 (75.0)
Negative 40 (27) 40 (100.0) 0 (0.0) 38 (95.0) 2 (5.0) 11 (27.5) 29 (72.5)
Ki67 status 9.292 0.002 1.996 0.158 3.987 0.046
<14% 106 (71.6) 105 (99.1) 1 (0.9) 93 (87.7) 13 (12.3) 32 (30.2) 74 (69.8)
≥14% 42 (28.4) 31 (88.1) 11 (11.9) 33 (78.6) 9 (21.4) 6 (14.3) 36 (85.7)
#

No: 0 CICs/core; Yes, ≥1 CICs/core. Lum: luminal. Bold values represent the statistical difference (p < 0.05).